Miyoshi, JinseiMannucci, AlessandroScarpa, MarcoGao, FengToden, ShusukeWhitsett, TimothyInge, Landon JBremner, Ross MTakayama, TetsujiCheng, YulanBottiglieri, TeodoroNagetaal, Iris DShrubsole, Martha JZaidi, Ali HWang, XinColeman, Helen GAnderson, Lesley AMeltzer, Stephen JGoel, AjayFINBAR-EMERALD2024-11-222024-11-222025-02Miyoshi, J, Mannucci, A, Scarpa, M, Gao, F, Toden, S, Whitsett, T, Inge, L J, Bremner, R M, Takayama, T, Cheng, Y, Bottiglieri, T, Nagetaal, I D, Shrubsole, M J, Zaidi, A H, Wang, X, Coleman, H G, Anderson, L A, Meltzer, S J, Goel, A & FINBAR-EMERALD 2025, 'Liquid biopsy to identify Barrett’s oesophagus, dysplasia and oesophageal adenocarcinoma : the EMERALD multicentre study', Gut, vol. 74, no. 2, pp. 169-181. https://doi.org/10.1136/gutjnl-2024-3333640017-5749crossref: 10.1136/gutjnl-2024-333364ORCID: /0000-0002-1000-3649/work/172466208https://hdl.handle.net/2164/24657Acknowledgments The FINBAR-EMERALD collaborators included Matteo Fassan and Elisabetta Trevellin (both from the 31 Department of Medicine, University of Padova, Italy) and Melania Scarpa (Lab of Advanced Translational Research, Veneto Institute of Oncology, IOV-IRCCS, Padova, Italy). The Factors INfluencing the Barrett’s Adenocarcinoma Relationship (FINBAR) study group members included the late Professor Liam J. Murray (Queen’s University Belfast), L. A. A. (Queen’s University Belfast), B. T. Johnston (Belfast Health & Social Care Trust), R. G. P. Watson (Belfast Health & Social Care Trust), J. McGuigan (Belfast Health & Social Care Trust), H. R. Ferguson (Belfast Health & Social Care Trust), S. J. Murphy (St Vincent’s Hospital Dublin), J. V. Reynolds (St James’ Hospital, Dublin) and H. Comber (National Cancer Registry of Ireland). Additionally, the authors thank Drs Caiming Xu, Silei Sui, Takayuki Noma, and Yuan Li for their thoughtful discussions and advice during this project.132737432engSubstantive connection via an eligible employment contractSDG 3 - Good Health and Well-beingEsophagus adenocarcinomaBarrett’s esophagusHigh-grade dysplasiaBiomarkermicroRNAR MedicineGastroenterologySupplementary InformationSupplementary DataDASRLiquid biopsy to identify Barrett’s oesophagus, dysplasia and oesophageal adenocarcinoma : the EMERALD multicentre studyJournal article10.1136/gutjnl-2024-333364https://abdn.elsevierpure.com/en/publications/23e0afe9-4792-4df8-829f-7ffa0e928ad2742